165. Cefiderocol Treatment for Serious Infections Caused by Carbapenem-resistant Bacteria: Post-hoc Analysis of Outcomes by Pathogen in the CREDIBLE-CR Study

MLA

Kiichiro Toyoizumi, et al. “165. Cefiderocol Treatment for Serious Infections Caused by Carbapenem-Resistant Bacteria: Post-Hoc Analysis of Outcomes by Pathogen in the CREDIBLE-CR Study.” Open Forum Infectious Diseases, vol. 7, Oct. 2020, p. S212. EBSCOhost, https://doi.org/10.1093/ofid/ofaa439.475.

APA

Kiichiro Toyoizumi, Yoshinori Yamano, Yuko Matsunaga, Tsutae Den Nagata, Masahiro Kinoshita, Miki Takemura, Roger Echols, & Mari Ariyasu. (2020). 165. Cefiderocol Treatment for Serious Infections Caused by Carbapenem-resistant Bacteria: Post-hoc Analysis of Outcomes by Pathogen in the CREDIBLE-CR Study. Open Forum Infectious Diseases, 7, S212. https://doi.org/10.1093/ofid/ofaa439.475

Chicago

Kiichiro Toyoizumi, Yoshinori Yamano, Yuko Matsunaga, Tsutae Den Nagata, Masahiro Kinoshita, Miki Takemura, Roger Echols, and Mari Ariyasu. 2020. “165. Cefiderocol Treatment for Serious Infections Caused by Carbapenem-Resistant Bacteria: Post-Hoc Analysis of Outcomes by Pathogen in the CREDIBLE-CR Study.” Open Forum Infectious Diseases 7 (October): S212. doi:10.1093/ofid/ofaa439.475.